U.S. markets open in 5 hours 58 minutes

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.76-0.24 (-1.26%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close19.00
Open19.00
Bid0.00 x 800
Ask0.00 x 1300
Day's Range18.55 - 19.26
52 Week Range13.02 - 27.85
Volume305,185
Avg. Volume867,347
Market Cap905.144M
Beta (5Y Monthly)1.64
PE Ratio (TTM)N/A
EPS (TTM)-1.88
Earnings DateAug 04, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Buy These 2 Stocks Before They Jump Over 60%, Says Analyst
    TipRanks

    Buy These 2 Stocks Before They Jump Over 60%, Says Analyst

    We’re in interesting times, there’s no doubt about that. The COVID crisis is receding, the economic reopening is proceeding apace – but there are inflationary worries. The Biden Administration is committed to a heavy spending program, including generous extended unemployment benefits – which in some cases can exceed wages. As a result, the labor market is apparently stuck, running in low gear and prompting some concern that the recovery may not gain traction. Taking a macro view of the economic

  • Syndax Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference
    PR Newswire

    Syndax Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference

    Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 2:10 p.m. ET.

  • Syndax Announces Participation in Cowen 2nd Annual Virtual Oncology Innovation Summit
    PR Newswire

    Syndax Announces Participation in Cowen 2nd Annual Virtual Oncology Innovation Summit

    Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in the Cowen 2nd Annual Virtual Oncology Innovation Summit on Thursday, May 20, 2021 at 12:00 p.m. ET.